Core Viewpoint - The company, Global Medical (02666), has received approval from the China Securities Regulatory Commission to publicly issue a maximum of RMB 2 billion in domestic renewable corporate bonds aimed at qualified investors, with a remaining quota of RMB 1.2 billion as of the announcement date [1] Group 1: Bond Issuance Details - The bond will be issued in tranches, with the total principal amount not exceeding RMB 850 million [1] - The basic term of the corporate bond is set at 3 years, with the issuer having the option to extend the term by one repricing cycle or fully redeem the bond at the end of the basic term and each repricing cycle [1] - The bond includes options for the issuer to extend the term, defer interest payments, and redeem the bond [1] Group 2: Interest Rate Structure - The interest rate for the first cycle will remain fixed and will be determined through a book-building process at the time of subscription [1] - The coupon rate is set as the initial benchmark rate plus an initial spread, with subsequent cycles resetting the coupon rate to the current benchmark rate plus the initial spread plus an additional 300 basis points [1] Group 3: Use of Proceeds - The net proceeds from the bond issuance will be used by the issuer to supplement operational funds [1]